Management of Upper Extremity Arterial and Venous ...

Management of Upper Extremity Arterial and

Venous Occlusive DiseasesCLAUDIE SHEAHAN MD

PROFESSOR OF CLINICAL SURGERYLSU SCHOOL OF MEDICINE

Upper extremity arterial disease

• Rare – less than 5% of PVD• Dutch study –

– Prevalence 2.3% diabetics – 0% non-diabetics

Clinical Presentation

• Episodic - Spastic• Claudication• Tissue loss

History and Physical

• Symptoms c/w connective tissue disorders– Arthralgias– Dysphagia– Sclerodactyly– Xeropthalmia– Xerostomia

History and Physical

Also look for signs of• Malignancy• Hypothyroidism• Frostbite• Trauma• Vibrating tools• Drug use

Examination

• Color change• Digital pitting• Digital ulcer • Gangrene

Exam

• Palpation of pulses• Auscultation for bruits• Adsons maneuvers-should be

done sitting• Allens test

Allen’s test

Collateral flow across the palmar arch

Cold provocation testing

Low specificity and reproducibility

Cardiac echo

Look for embolization

potential

X-Rays

• Cervical rib• Soft tissue atrophy• Distal phalangeal tuft

reabsorption

Biopsy

• Skin for vasculitis• SSc atrophy of epidermis and adnexal fat• Arteritis- wall necrosis

Vascular lab• Multiple level segmental

pressures • Multiple level pulse volume

plethysmography (PVR)• Digital pressures /PPG• ABI• DBI (digital brachial index) ≥0.75

Vascular lab

• Demonstrate symmetry – Between arms– Lower extremities

• Gradient 30-50 mmHg with subclavian artery occlusion

• Digital plethysmography for differentiating vasospasm vs occlusive lesion

Angiography

• Aortic arch: atherosclerosis, ulceration, aneurysms

• TOS maneuvers • Retrograde flow in vertebral

“Subclavian Steal”• Vasodilators, hand warming,

magnified view

Angiography in collagen vascular diseases

• Absence of calcium• Total occlusion vs string • Multiple segmental lesions • Less developed collaterals

Upper extremity arterial disease

Occlusive vs. Spastic

Raynaud's Syndrome

•Vasospastic•Primary•Raynaud’s Disease

•Idiopathic

•Obstructive•Secondary•Raynaud’s Phenomena

Primary Raynaud’s

• Exaggerated response to cold, emotional stimuli

• 3 stages: White, Blue, Red• 15-20min episodes• Pain usually absent • Thermal threshold varies 17-26°C

Primary Raynaud’s

• Most common• Benign• Does not lead to severe ischemia

Secondary Raynaud’s

• More likely to progress to severe occlusive lesions within the digital arteries

• Rest pain and ulceration• Associated with Systemic Sclerosis SLE, RA, mixed collagen disease

Epidemiology

• Mostly women• Median age onset 14• Prevalence varies with climate• Study from Portland 30%

incidence• Higher risk in first degree

relative

Pathophysiology

“Local asphyxia of the extremities" was a result of "increased irritability of the central parts of the cord presiding over the vascular innervation"

-Maurice Raynaud 1862

Pathophysiology

“Local fault”

-Sir Thomas Lewis 1930

Bloodwork

• CBC• ESR/CRP• ANA• Biochemical profile• Thyroid function• RF• CXR/thoracic outlet

Nailfold Capilloroscopy

• Early manifestation of scleroderma

• Dilated capillaries, areas of avascularity

Nailfold Capilloroscopy

• Nailfold capillaries lie parallel rather than ꓕ

• Abnormalities not present in vasospastic disease

• Independent predictor for SScdevelopment

1° vs 2° Raynaud's

• Digital ischemia may precede systemic manifestations of these secondary diseases, makes diagnosis more difficult

• % of patients who go on to develop secondary Raynaud’s

Management of Primary Raynaud’s

• Cold avoidance, Gloves• Stop smoking• Stop beta blockers• Stop ergot preparations

(migraine therapy)• Biofeedback doesn’t work

Medical management of Raynaud's

First line therapy – calcium channel blockers

–Procardia XL (nifedipine) 30-60mg qd to bid–Norvasc (amlodipine) 5-10mg qd


Second line therapy with proven efficacy• Angiotensin II RCP blockade (losartan) • ACE Inhibitors (enalopril)• (Prozac) Fluoxetine• Alpha blockers (prazosin)

Alpha blockers reserpine


• Topical vasodilators (GTN)• IV prostanoid (Iloprost)• Endothelin RCP antagonist (Bosentan) • +/- antiplatelets

PDE5 Inhibitors

• Increase availability of NO• Second choice for secondary Raynaud's• Sildenafil (Viagra) 20-25 mg TID

Raynaud's syndrome disordersless than 1% of all Raynaud's

• Immunological and connective tissue disorders– Scleroderma– Mixed CT disease– RA– SLE– Dermatomyositis– Polymyositis– Hep B antigen induced vasculitis– Sjogrens syndrome– Drug induced vasculitis– Hypersensitivity angiitis– Undifferentiated CT disease– Antiphospholipid syndrome

• Obstructive arterial diseases– Atherosclerosis– buergers syndrome– TOS

• Environmental conditions– Vibration injury– Direct arterial trauma– Cold injury

• Drug induced Raynaud's syndrome without vasculitis– Ergot– B blockers– Cytotoxic drugs– OCPS

• Miscellaneous– Vinyl chloride disease– CRF– Cold agglutinins– Cryoglobulinemia– Neoplasia– Neurologic disorders– Endocrine disorders

Small Vessel Occlusion

Mechanism of obstruction is variable–Autoimmune vasculitis - widespread digital and

palmar artery occlusions


Vibrating tools- fibrotic form of

palmar and digital artery obstruction

- presumably shear stress


Pathophysiology–Hypercoagulable states–Embolic–Atherosclerotic–Renal failure

Small vessel occlusion

Gangrene • Usually occlusive disease-either digital or palmar arch. • BUT a proximal embolizing or obstructing lesion should be

looked for• Process of digital gangrene is different from necrosis-it is not

suppurative but a process of desication and mummification

Medical management

• No abx ointment-will dessicate

• Occasional suppurativeprocess requires iv abx, possible debridement

• Auto-amputation

Surgical therapy

• Cervical thoracic sympathectomy results are too short

• Perineural neurectomy• Fat grafting• Botox• Occasionally PTA

Surgical therapy

• Amputation rarely indicated• Spinal cord stimulation

Scleroderma

• Raynaud's phenomena present in 95% pts

• 40-50% pts will have a digital ulcer in their lifetime

Hypothenar Hammer Syndrome

• Male• Sudden onset• Unilateral


• Visible/palpable mass by hypothenar eminence due to ulnar artery aneurysm

• Aneurysm may embolize• May also present with thrombosis

Vasculitis of Malignancy

• Hairy cell leukemia– Systemic necrotizing vasculitis

• “Paraneoplastic” vasculitides• Vasculitis with solid tumors

Drug Abuse Vasculitis

• IVDA of meth or cocaine is associated with pan arteritis

• Accidental arterial injection • Treatment

– Heparin, debridement

Antiphospholipid Syndrome

• Acquired autoimmune disorder• Recurrent arterial and venous thrombosis – anywhere• Thrombotic events treated with anticoagulation

Ergotism

• Most cases due to ergot alkaloid treatments

• Can cause severe spasm of digital vessels - gangrene

Thromboangiitis Obliterans (TO)

• Formerly known as Buerger’s• Segmental medium and small vessel occlusion • Arms and legs• 40-50% pts have history of superficial migratory

thrombophlebitis, Raynaud’s or both


• USA• 10% isolated UE involvement• 30-40% UE and LE involvement• 50% LE


Arterial wall inflammatory infiltrate

Etiology unknown – Tobacco is permissive, probably

causative

Diagnosis

Essential Criteria• Onset of sx <45

• Tobacco use

• No disease proximal to popliteal artery

• No disease proximal to distal brachial artery

• Objective documentation distal occlusive disease

Supportive Criteria• Superficial thrombophlebitis

• Raynaud’s

• UE involvement

Differential Diagnosis

Must exclude:• Proximal embolic source• Trauma and local lesion• Autoimmune disease• Hypercoagulable state• Atherosclerosis• Atherosclerotic risk factors (DM, HTN, Hyperlipidemia)

Angiography

• Symmetric

• Radial or ulnar occlusion

• Segmental rather than diffuse

• Extensive digital and palmar artery occlusive disease

Treatment

• Stop smoking• Palliative• Remissions related to resumption of smoking• Limb salvage not as good as with atherosclerosis• Normal life expectancy, no coronary involvement

Large Vessel Arteritis

• Giant Cell• Radiation induced

Giant Cell Arteritis

Systemic GCA (temporal arteritis) vs. Takayasu’s arteritis

Giant Cell Arteritis

Systemic GCA (temporal arteritis)• Usually carotid artery branches

• But any branches

• Most often complaint is severe pain along course of temporal artery

• Women older than 50

Systemic GCA

Diagnosis• Biopsy

• Duplex may be helpful

Treatment• Prompt steroid therapy

• MTX

• Cyclosporin, Azathioprine

• TNF inhibitors

• Pyrimidine synthesis inhibitors

Takayasu’s Arteritis

• Younger patients, female more often

• Smooth tapered stenosis of subclavian, axillary, brachial

• Can cause stenosis of aorta and its branches, main difference is pulmonary artery involvement

• Thoracic aortic aneurysm 17x risk

• AAA 2.4x risk


Pediatric

• Not as strong sex predilection

• Heart failure is common

• 75% survival at 20 yrs, heart failure driven

• HTN

• Also, myocarditis, coronary artery involvement, valvular involvement, pulmonary involvement


• Two stages of illness– Acute – Chronic

• Same medications used as temporal arteritis

• Results not as consistent as with TA

Surgical Intervention

• Best done in quiescent (chronic) state

• Symptomatic stenosis

• Aneurysmal lesions

Surgical Intervention

• Successful surgery requires bypass to normal artery

• Continue steroid therapy

• PTA higher restenosis rate than expected, 90%

Surveillance

• Follow ESR, CRP

• PET-CT scan

Upper Extremity Acute Arterial Insufficiency

50% - embolization• mostly cardiac• also aneurysm brachiocephalic/subclavian

25% - primary arterial thrombosis25% - iatrogenic

• ABGs• A lines• AVF creation

Upper Extremity Acute Arterial Insufficiency

• Embolization is associated with 25% mortality–Recurrence and embolization to other vascular beds

• Renal, Mesenteric, Cerebral

Revascularization

• Thrombectomy• Endovascular• Combined

Repetitive Trauma

• Quadrilateral space syndrome-axillary artery injury

• Humeral head syndrome- post humeral circumflex artery injury

• Both lead to embolization• Common in throwing athletes

Large Vessel Occlusive Disease

• Atherosclerosis- most common

• Same risk factors as lower extremity

• Diabetes, renal failure lesions may involve large and small vessels

Large Vessel Occlusive Disease

AneurysmSubclavian and axillary – most common

Iatrogenic venous disease

• Trauma• IV access• PICC lines• Dialysis catheters

COVID 19 – Acute Limb Ischemia

• Thrombotic etiology predominates

• Can occur in pts receiving thromboprophylaxis

COVID 19- Acute Limb Ischemia

• Risk factors – Older age– Obesity– Cardiovascular comorbidities

• More typically affects patients with severe COVID-19

• Occurs five to seven days after respiratory decompensation


• Thrombosis of large or medium-sized arteries have all been reported.

• Small vessel thrombosis leading to digital gangrene is often associated with the administration of vasopressor agents.


• About 20 percent of patients who present with COVID-19 related ALI have few or no respiratory symptoms.

• Furthermore, ALI can occur during the recovery phase following infection of any severity.

Management of Upper Extremity Arterial and Venous ...

Documents

Transcript of Management of Upper Extremity Arterial and Venous ...